{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:38:20Z","timestamp":1793216300044,"version":"4.5.0"},"publisher-location":"Cham","reference-count":98,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030573614","type":"print"},{"value":"9783030573621","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-57362-1_4","type":"book-chapter","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T22:02:50Z","timestamp":1605564170000},"page":"71-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevention of Hepatitis B Virus Infection and Liver Cancer"],"prefix":"10.1007","author":[{"given":"Mei-Hwei","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","unstructured":"Athuluri-Divakar SK, Hoshida Y. (2018) Generic chemoprevention of hepatocellular carcinoma. Ann N Y Acad Sci (17 September, 2018). https:\/\/doi.org\/10.1111\/nyas.13971. Epub ahead of print","DOI":"10.1111\/nyas.13971"},{"key":"4_CR2","first-page":"21s","volume":"2","author":"RP Beasley","year":"1982","unstructured":"Beasley RP (1982) Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 2:21s\u201326s","journal-title":"Hepatology"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","volume":"2","author":"RP Beasley","year":"1981","unstructured":"Beasley RP, Hwang LY, Lin CC et al (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2:1129\u20131133","journal-title":"Lancet"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/oxfordjournals.aje.a112370","volume":"105","author":"RP Beasley","year":"1977","unstructured":"Beasley RP, Trepo C, Stevens CE et al (1977) The e antigen and vertical transmission of hepatitis B surface antigen. Amer J Epidemiol 105:94\u201398","journal-title":"Amer J Epidemiol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/bjs.6731","volume":"96","author":"S Braitenstein","year":"2009","unstructured":"Braitenstein S, Dimitroulis D, Petrowsky H et al (2009) Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Br J Surg 96:975\u2013981","journal-title":"Br J Surg"},{"key":"4_CR6","first-page":"1","volume-title":"Viruses and liver cancer","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Ribes J (2002) The epidemiology of primary liver cancer: global epidemiology. In: Tabor E (ed) Viruses and liver cancer. Elsevier Science, Amsterdam, pp 1\u201316"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","volume":"5","author":"J Bruix","year":"2004","unstructured":"Bruix J, Boix L, Sala M et al (2004) Focus on hepatocellular carcinoma. Cancer Cell 5:215\u2013219","journal-title":"Cancer Cell"},{"key":"4_CR8","first-page":"1208","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. AASLD Guideline recommendations for HCC screening, Hepatology 42:1208\u20131236","journal-title":"AASLD Guideline recommendations for HCC screening, Hepatology"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0168-8278(01)00005-8","volume":"34","author":"C Camm\u00e0","year":"2001","unstructured":"Camm\u00e0 C, Giunta M, Andreone P et al (2001) Interferon and prevention of hepatocellular carcinoma\u00a0in viral cirrhosis: an evidence-based approach. J Hepatol 34:593\u2013602","journal-title":"J Hepatol"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrgastro.2013.137","volume":"10","author":"MH Chang","year":"2013","unstructured":"Chang MH (2013) Paediatrics: Children need optimal management of chronic hepatitis B. Nat Rev Gastroenterol Hepatol. 10:505\u2013506","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","volume":"336","author":"MH Chang","year":"1997","unstructured":"Chang MH, Chen CJ, Lai MS et al (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336:1855\u20131859","journal-title":"N Engl J Med"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8","volume":"64","author":"MH Chang","year":"1989","unstructured":"Chang MH, Chen DS, Hsu HC et al (1989) Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 64:2377\u20132380","journal-title":"Cancer"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/hep.1840130218","volume":"13","author":"MH Chang","year":"1991","unstructured":"Chang MH, Chen PJ, Chen JY et al (1991) Hepatitis B virus integration in hepatitis B virus-related hepatocellularcarcinoma in childhood. Hepatology 13:316\u2013320","journal-title":"Hepatology"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1158\/1078-0432.CCR-05-1095","volume":"11","author":"MH Chang","year":"2005","unstructured":"Chang MH, Chen TH, Hsu HM et al (2005) Problems in the prevention of childhood hepatocellular carcinoma in the era of universal hepatitis B immunization. Clin Cancer Res 11:7953\u20137957","journal-title":"Clin Cancer Res"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/1097-0142(19840415)53:8<1807::AID-CNCR2820530835>3.0.CO;2-J","volume":"53","author":"MH Chang","year":"1984","unstructured":"Chang MH, Hsu HC, Lee CY et al (1984) Fraternal hepatocellular carcinoma in young children in two families. Cancer 53:1807\u20131810","journal-title":"Cancer"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0168-8278(96)80262-5","volume":"24","author":"MH Chang","year":"1996","unstructured":"Chang MH, Hsu HY, Huang LM et al (1996) The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus. J Hepatol 24:674\u2013679","journal-title":"J Hepatol"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1001\/jama.284.23.3040","volume":"284","author":"MH Chang","year":"2000","unstructured":"Chang MH, Shau WY, Chen CJ et al (2000) The effect of universal hepatitis B vaccination on hepatocellular carcinoma rates in boys and girls. JAMA 284:3040\u20133042","journal-title":"JAMA"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/jnci\/djp288","volume":"101","author":"MH Chang","year":"2009","unstructured":"Chang MH, You SL, Chen CJ et al (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101:1348\u20131355","journal-title":"J Natl Cancer Inst"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/j.gastro.2016.05.048","volume":"151","author":"MH Chang","year":"2016","unstructured":"Chang MH, You SL, Chen CJ et al (2016) Long-term effects of hepatitis B immunization of infants in preventing liver cancer. Gastroenterology 151:472\u2013480","journal-title":"Gastroenterology"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J et al (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65\u201373","journal-title":"JAMA"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2008.03.073","volume":"135","author":"CL Chen","year":"2008","unstructured":"Chen CL, Yang HI, Yang WS et al (2008) Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B\/C infection: a follow-up study in Taiwan. Gastroenterology 135:111\u2013121","journal-title":"Gastroenterology"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","volume":"257","author":"DS Chen","year":"1987","unstructured":"Chen DS, Hsu NHM, Sung JL et al (1987) A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257:2597\u20132603","journal-title":"JAMA"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.1996.03540110060032","volume":"276","author":"HL Chen","year":"1996","unstructured":"Chen HL, Chang MH, Ni YH et al (1996) Seroepidemiology of hepatitis B virus infection in children: ten years after a hepatitis B mass vaccination program in Taiwan. JAMA 276:906\u2013908","journal-title":"JAMA"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","volume":"142","author":"HL Chen","year":"2012","unstructured":"Chen HL, Lin LH, Hu FC et al (2012) Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142:773\u2013781","journal-title":"Gastroenterology"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/hep.27837","volume":"62","author":"HL Chen","year":"2015","unstructured":"Chen HL, Lee CN, Chang CH et al (2015) Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 62:375\u2013386","journal-title":"Hepatology"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/hep.23348","volume":"51","author":"YC Chen","year":"2010","unstructured":"Chen YC, Chu CM, Liaw YF (2010) Age- specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology 51:435\u2013444","journal-title":"Hepatology"},{"key":"4_CR28","first-page":"475","volume":"66","author":"MC Chien","year":"1981","unstructured":"Chien MC, Tong MJ, Lo KJ et al (1981) Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. J Natl Cancer Inst 66:475\u2013479","journal-title":"J Natl Cancer Inst"},{"key":"4_CR29","first-page":"79","volume":"116","author":"CS Coffin","year":"2015","unstructured":"Coffin CS, Lee SS (2015) New paradigms in hepatitis B management: only diamonds are forever. Br Med Bull 116:79\u201391","journal-title":"Br Med Bull"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/hep.27996","volume":"62","author":"HH Chua","year":"2015","unstructured":"Chua HH, Tsuei DJ, Lee PH et al (2015) RBMY, a novel inhibitor of glycogen synthase kinase 3\u03b2, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma. Hepatology 62:1480\u20131496","journal-title":"Hepatology"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/0264-410X(95)00056-7","volume":"13","author":"G Da Villa","year":"1995","unstructured":"Da Villa G, Picciottoc L, Elia S et al (1995) Hepatitis B vaccination: Universal vaccination of newborn babies and children at 12\u00a0years of age versus high risk groups: a comparison in the field. Vaccine 13:1240\u20131243","journal-title":"Vaccine"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"14601","DOI":"10.1073\/pnas.251536898","volume":"98","author":"PA Egner","year":"2001","unstructured":"Egner PA, Wang JB, Shu YR et al (2001) Chlorophyline intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98:14601\u201314606","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR33","first-page":"269","volume-title":"The molecular basis of human cancer","author":"JW Grisham","year":"2001","unstructured":"Grisham JW (2001) Molecular genetic alterations in primary hepatocellular neoplasms. In: Coleman WB, Tsongalis GJ (eds) The molecular basis of human cancer. Humana Press, Totowa, NJ, pp 269\u2013346"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00006454-199901000-00007","volume":"18","author":"NA Halsey","year":"1999","unstructured":"Halsey NA, Duclos P, van Damme P et al (1999) Hepatitis B vaccine and central nervous system demyelinating diseases. Pediatrc Infect Dis J 18:23\u201324","journal-title":"Pediatrc Infect Dis J"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","volume":"55","author":"GR Han","year":"2011","unstructured":"Han GR, Cao MK, Zhao W et al (2011) A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 55:1215\u20131221","journal-title":"J Hepatol"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ijc.2910280109","volume":"28","author":"WL Heyward","year":"1981","unstructured":"Heyward WL, Lanier AP, Bender TR et al (1981) Primary hepatocellular carcinoma in Alaskan Natives, 1969\u20131979. Int J Cancer 28:47\u201350","journal-title":"Int J Cancer"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/hep.26180","volume":"58","author":"T Hosaka","year":"2013","unstructured":"Hosaka T, Suzuki F, Kobayashi M et al (2013) Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 58:98\u2013107","journal-title":"Hepatology"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/1097-0142(19831115)52:10<1825::AID-CNCR2820521011>3.0.CO;2-M","volume":"52","author":"HC Hsu","year":"1983","unstructured":"Hsu HC, Lin WS, Tsai MJ (1983) Hepatitis B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells. Cancer 52:1825\u20131832","journal-title":"Cancer"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jmv.1890180402","volume":"18","author":"HY Hsu","year":"1986","unstructured":"Hsu HY, Chang MH, Chen DS et al (1986) Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: A study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 18:301\u2013307","journal-title":"J Med Virol"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/hep.1840150505","volume":"15","author":"HY Hsu","year":"1992","unstructured":"Hsu HY, Chang MH, Hsieh KH et al (1992) Cellular immune response to hepatitis B core antigen in maternal-infant transmission of hepatitis B virus. Hepatology 15:770\u2013776","journal-title":"Hepatology"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.510300511","volume":"30","author":"HY Hsu","year":"1999","unstructured":"Hsu HY, Chang MH, Liaw SH et al (1999) Changes of hepatitis B surface variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312\u20131317","journal-title":"Hepatology"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1086\/651378","volume":"201","author":"HY Hsu","year":"2010","unstructured":"Hsu HY, Chang MH, Ni YH et al (2010) Twenty-year trends in the emergence of hepatitis B surface antigen variants in children and adolescents after universal vaccination in Taiwan. J Infect Dis 201:1192\u20131200","journal-title":"J Infect Dis"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jvh.12832","volume":"25","author":"YC Hsu","year":"2018","unstructured":"Hsu YC, Ho HJ, Lee TY et al (2018) Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir. J Viral Hepat. 25:543\u2013551","journal-title":"J Viral Hepat."},{"key":"4_CR01","doi-asserted-by":"crossref","unstructured":"Hsu HY, Chang MH, Ni YH, Chen HL (2004) Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination program in Taiwan. Gut 53:1499\u20131503","DOI":"10.1136\/gut.2003.034223"},{"key":"4_CR45","unstructured":"International Agency for Research on Cancer, World Health Organization (2018) Cancer today. http:\/\/gco.iarc.fr\/today\/fact-sheets-cancers. Accessed December 29, 2018"},{"key":"4_CR46","first-page":"257","volume":"6","author":"LP Jacobson","year":"1997","unstructured":"Jacobson LP, Zhang BC, Shu YR et al (1997) Oltipratz chemoprevention trial in Qidong, People\u2019s Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6:257\u2013265","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3904\/kjim.2001.16.3.153","volume":"16","author":"MK Jang","year":"2001","unstructured":"Jang MK, Lee JY, Lee JH et al (2001) Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med 16:153\u2013159","journal-title":"Korean J Intern Med"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/jnci\/djh334","volume":"96","author":"SH Jee","year":"2004","unstructured":"Jee SH, Ohrr H, Sull JW et al (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96:1851\u20131855","journal-title":"J Natl Cancer Inst"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(05)65598-5","volume":"348","author":"MA Kane","year":"1996","unstructured":"Kane MA (1996) Global status of hepatitis B immunization. Lancet 348:696","journal-title":"Lancet"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00001432-200210000-00002","volume":"15","author":"MA Kane","year":"2002","unstructured":"Kane MA, Brooks A (2002) New immunization initiatives and progress toward the global control of hepatitis B. Current Opinion in Infectious Diseases 15:465\u2013469","journal-title":"Current Opinion in Infectious Diseases"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2217\/fvl.14.36","volume":"9","author":"R Kapoor","year":"2014","unstructured":"Kapoor R, Kottilil S (2014) Strategies to eliminate HBV infection. Future Virol 9:565\u2013585","journal-title":"Future Virol"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep.25937","volume":"57","author":"CL Lai","year":"2013","unstructured":"Lai CL, Yuen MF (2013) Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology 57:399\u2013408","journal-title":"Hepatology"},{"key":"4_CR53","doi-asserted-by":"crossref","unstructured":"Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis 11:97\u2013107","DOI":"10.1046\/j.1365-2893.2003.00487.x"},{"key":"4_CR54","doi-asserted-by":"crossref","unstructured":"Lavanchy D (2008) Chronic viral hepatitis as a public health issue in the world. Best Pract Res Clin Gastroenterol 22:991\u20131008","DOI":"10.1016\/j.bpg.2008.11.002"},{"issue":"Suppl 5","key":"4_CR55","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1245\/s10434-016-5520-9","volume":"23","author":"PC Lee","year":"2016","unstructured":"Lee PC, Yeh CM, Hu YW et al (2016) Antiplatelet therapy is associated with a better prognosis for patients with hepatitis B virus-related hepatocellular carcinoma after liver resection. Ann Surg Oncol 23(Suppl 5):874\u2013883","journal-title":"Ann Surg Oncol"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/hep.1840060306","volume":"6","author":"SD Lee","year":"1986","unstructured":"Lee SD, Lo KJ, Wu JC et al (1986) Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology 6:369\u2013373","journal-title":"Hepatology"},{"key":"4_CR57","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC et al (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521\u20131531","journal-title":"N Engl J Med"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cld.2013.05.005","volume":"17","author":"YF Liaw","year":"2013","unstructured":"Liaw YF (2013) Impact of therapy on the long-term outcome of chronic hepatitis B. Clin Liver Dis 17:413\u2013423","journal-title":"Clin Liver Dis"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0264-410X(91)90135-S","volume":"9","author":"HH Lin","year":"1991","unstructured":"Lin HH, Chang MH, Chen DS et al (1991) Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: Analysis of prophylaxis failure. Vaccine 9:457\u2013460","journal-title":"Vaccine"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0022-3476(87)80210-X","volume":"111","author":"HH Lin","year":"1987","unstructured":"Lin HH, Lee TY, Chen DS et al (1987) Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis intrauterine infection with hepatitis B virus. J Pediatr 111:877\u2013881","journal-title":"J Pediatr"},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2006.08.021","volume":"46","author":"SM Lin","year":"2007","unstructured":"Lin SM, Yu ML, Lee CM et al (2007) Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma. J Hepatol 46:45\u201352","journal-title":"J Hepatol"},{"issue":"5\u201311","key":"4_CR62","first-page":"1","volume":"195","author":"SE Livingston","year":"2007","unstructured":"Livingston SE, Simonetti J, McMahon B et al (2007) Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195(5\u201311):1","journal-title":"J Infect Dis"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/hep.24442","volume":"54","author":"BJ McMahon","year":"2011","unstructured":"McMahon BJ, Bulkow LR, Singleton RJ et al (2011) Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 Years after a hepatitis B newborn and catch-up immunization program. Hepatology 54:801\u2013807","journal-title":"Hepatology"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00535-009-0024-z","volume":"44","author":"Y Miyake","year":"2009","unstructured":"Miyake Y, Kobashi H, Yamamoto K (2009) Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol 44:470\u2013475","journal-title":"J Gastroenterol"},{"issue":"Suppl 1","key":"4_CR65","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1476-069X-10-S1-S6","volume":"10","author":"R Montesano","year":"2011","unstructured":"Montesano R (2011) Preventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa). Environmental Health 10(Suppl 1):S6","journal-title":"Environmental Health"},{"key":"4_CR66","first-page":"1737","volume":"68","author":"YH Ni","year":"1991","unstructured":"Ni YH, Chang MH, Hsu HY et al (1991) Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 68:1737\u20131741","journal-title":"Clinical manifestations and prognosis. Cancer"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7326\/0003-4819-135-9-200111060-00009","volume":"135","author":"YH Ni","year":"2001","unstructured":"Ni YH, Chang MH, Huang LM et al (2001) Hepatitis B virus infection in children and adolescents in an hyperendemic area: 15\u00a0years after universal hepatitis B vaccination. Ann Intern Med 135:796\u2013800","journal-title":"Ann Intern Med"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","volume":"132","author":"YH Ni","year":"2007","unstructured":"Ni YH, Huang LM, Chang MH et al (2007) Two decades of universal hepatitis B vaccination in Taiwan: Impact and implication for future strategies. Gastroenterology 132:1287\u20131293","journal-title":"Gastroenterology"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cgh.2016.04.030","volume":"14","author":"YH Ni","year":"2016","unstructured":"Ni YH, Chang MH, Jan CF et al (2016) Continuing decrease in hepatitis B virus infection 30\u00a0years after initiation of infant vaccination program in Taiwan. Clin Gastroenterol Hepatol 14:1324\u20131330","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/hep.29320","volume":"66","author":"GV Papatheodoridis","year":"2017","unstructured":"Papatheodoridis GV, Idilman R, Dalekos GN et al (2017) The risk of hepatocellular carcinoma decreases after the first 5\u00a0years of entecavir or tenofovir in caucasians with chronic hepatitis B. Hepatology 66:1444\u20131453","journal-title":"Hepatology"},{"key":"4_CR72","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153\u2013156","journal-title":"Int J Cancer"},{"key":"4_CR73","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1001\/jama.1989.03420220092033","volume":"261","author":"Y Poovorawan","year":"1989","unstructured":"Poovorawan Y, Sanpavat S, Pongpunlert W et al (1989) Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 261:3278\u20133281","journal-title":"JAMA"},{"key":"4_CR74","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(98)09148-X","volume":"353","author":"DF Schafer","year":"1999","unstructured":"Schafer DF, Sorrell MF (1999) Hepatocellular carcinoma. Lancet 353:1253\u20131257","journal-title":"Lancet"},{"key":"4_CR02","doi-asserted-by":"crossref","unstructured":"Serigado JM, Izzy M, Kalia H (2017) Novel therapies and potential therapeutic targets in the management of chronic hepatitis B. Eur J Gastroenterol Hepatol 29:987\u2013993","DOI":"10.1097\/MEG.0000000000000911"},{"key":"4_CR75","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard CW, Simard EP, Finelli L et al (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112\u2013125","journal-title":"Epidemiol Rev"},{"key":"4_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/hep.26317","volume":"58","author":"M Sherman","year":"2013","unstructured":"Sherman M (2013) Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma? Hepatology 58:18\u201320","journal-title":"Hepatology"},{"key":"4_CR77","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM197504102921503","volume":"292","author":"CE Stevens","year":"1975","unstructured":"Stevens CE, Beasley RP, Tsui J et al (1975) Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292:771\u2013774","journal-title":"N Engl J Med"},{"key":"4_CR78","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/liv.13253","volume":"36","author":"TH Su","year":"2016","unstructured":"Su TH, Hu TH, Chen CY et al (2016) C-TEAM study group and the Taiwan Liver diseases consortium. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. Liver Int. 36:1755\u20131764","journal-title":"Liver Int."},{"key":"4_CR79","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0022-3476(98)70272-0","volume":"133","author":"JR Tang","year":"1998","unstructured":"Tang JR, Hsu HY, Lin HH et al (1998) Hepatitis B surface antigenemia at birth: a longterm follow-up study. J Pediatr 133:374\u2013377","journal-title":"J Pediatr"},{"key":"4_CR80","first-page":"587","volume-title":"World cancer report 2014","author":"MR Thursz","year":"2014","unstructured":"Thursz MR (2014) Treating chronic hepatitis with antiviral drugs to prevent liver cancer. In: Steward Bernard W, Wild Christopher P (eds) World cancer report 2014. WHO, IARC, pp 587\u2013593"},{"key":"4_CR81","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","volume":"142","author":"TC Tseng","year":"2012","unstructured":"Tseng TC, Liu CJ, Yang HC et al (2012) High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenteorlogy 142:1140\u20131149","journal-title":"Gastroenteorlogy"},{"key":"4_CR82","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.24794","volume":"55","author":"F Turati","year":"2012","unstructured":"Turati F, Edefonti V, Talamini R et al (2012) Family history of liver cancer and hepatocellular carcinoma. Hepatology 55:1416\u20131425","journal-title":"Hepatology"},{"key":"4_CR83","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.bpg.2008.11.008","volume":"22","author":"K Van Herck","year":"2008","unstructured":"Van Herck K, Vorsters A, Van Damme P (2008) Prevention of viral hepatitis (B and C) reassessed. Best Pract Res Clin Gastroenterol 22:1009\u20131029","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"4_CR84","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.1365-2893.2003.00440.x","volume":"10","author":"M van Zonneveld","year":"2003","unstructured":"van Zonneveld M, van Nunen AB, Niesters HG et al (2003) Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 10:294\u2013297","journal-title":"J Viral Hepat"},{"key":"4_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-2006-960171","volume":"27","author":"A Villanueva","year":"2007","unstructured":"Villanueva A, Newell P, Chiang DY et al (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55\u201376","journal-title":"Semin Liver Dis"},{"key":"4_CR86","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","volume":"97","author":"HC Wang","year":"2006","unstructured":"Wang HC, Huang W, Lai MD et al (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683\u2013688","journal-title":"Cancer Sci"},{"key":"4_CR87","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.325.7364.569","volume":"325","author":"H Whittle","year":"2002","unstructured":"Whittle H, Jaffar S, Wansbrough M et al (2002) Observational study of vaccine efficacy 14\u00a0years after trial of hepatitis B vaccination in Gambian children. BMJ 325:569\u2013573","journal-title":"BMJ"},{"key":"4_CR88","first-page":"507","volume":"9","author":"K Wichajarn","year":"2008","unstructured":"Wichajarn K, Kosalaraksa P, Wiangnon S (2008) Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program. Asian Pac J Cancer Prev 9:507\u2013509","journal-title":"Asian Pac J Cancer Prev"},{"key":"4_CR89","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1365-2036.2010.04447.x","volume":"32","author":"GL Wong","year":"2010","unstructured":"Wong GL, Yiu KK, Wong VW et al (2010) (2010) Metaanalysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B. Aliment Pharmacol Ther 32:1059\u20131068","journal-title":"Aliment Pharmacol Ther"},{"key":"4_CR90","unstructured":"World Health Organization (2017) Global hepatitis report 2017. Geneva, Switzerland"},{"key":"4_CR91","unstructured":"World Health Organization (2019). (https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed January, 2019"},{"key":"4_CR92","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"CY Wu","year":"2012","unstructured":"Wu CY, Chen YJ, Ho HJ et al (2012) (2012) Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308:1906\u20131914","journal-title":"JAMA"},{"key":"4_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1053\/j.gastro.2014.03.048","volume":"147","author":"CY Wu","year":"2014","unstructured":"Wu CY, Lin JT, Ho HJ et al (2014) Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study. Gastroenterology 147:143\u2013151","journal-title":"Gastroenterology"},{"key":"4_CR94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","volume":"16","author":"WM Xu","year":"2009","unstructured":"Xu WM, Cui YT, Wang L et al (2009) Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 16:94\u2013103","journal-title":"J Viral Hepat"},{"key":"4_CR95","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJMoa013215","volume":"347","author":"HI Yang","year":"2002","unstructured":"Yang HI, Lu SN, Liaw YF et al (2002) Hepatitis B e antigen and the risks of hepatocellular carcinoma. N Engl J Med 347:168\u2013174","journal-title":"N Engl J Med"},{"key":"4_CR96","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12072-015-9661-x","volume":"10","author":"N Yang","year":"2016","unstructured":"Yang N, Bertoletti A (2016) Advances in therapeutics for chronic hepatitis B. Hepatol Int 10:277\u2013285","journal-title":"Hepatol Int"},{"key":"4_CR97","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2893.2009.01070.x","volume":"16","author":"YF Yang","year":"2009","unstructured":"Yang YF, Zhao W, Zhong YD et al (2009) Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis. J Viral Hepat. 16:265\u2013271","journal-title":"J Viral Hepat."},{"issue":"suppl 1","key":"4_CR98","first-page":"172","volume":"78","author":"SH Yeh","year":"2012","unstructured":"Yeh SH, Chen PJ (2012) Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78(suppl 1):172\u2013179","journal-title":"Oncology"},{"key":"4_CR99","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a009060","volume":"145","author":"MW Yu","year":"1997","unstructured":"Yu MW, Hsu FC, Sheen IS et al (1997) Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145:1039\u20131047","journal-title":"Am J Epidemiol"}],"container-title":["Recent Results in Cancer Research","Viruses and Human Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-57362-1_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T22:03:49Z","timestamp":1605564229000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-57362-1_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"ISBN":["9783030573614","9783030573621"],"references-count":98,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-57362-1_4","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"18 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}